Open evenings and weekends
Mon to Fri 6–9 PM · Sat 10 AM–5 PM · Sun 1–4 PM ET
Request a free consultation anytime
How GLP-1 medication works, what the trial data really says, and what a supervised program looks like month to month.
Georgia has an obesity problem, and the numbers are not subtle. Using 2024 Behavioral Risk Factor Surveillance System data, America's Health Rankings puts Georgia's adult obesity rate at 35.4%, above the national figure of 34.2%. More than a third of the men you pass on Newcastle Street meet the clinical definition.
Most of them have already tried. Usually several times. That is the part the statistics leave out, and it is the reason GLP-1 medication has become the most asked-about topic in men's health over the last three years.
Here is a straight read on what semaglutide is, what the research actually found, and what a supervised program looks like month to month.
Semaglutide belongs to a class of medications called GLP-1 receptor agonists. Cleveland Clinic describes them as drugs that mimic the natural GLP-1 hormone your body already produces, and they work along several pathways at once:
That last mechanism is the one men describe most vividly. The constant background negotiation with food quiets down. Cleveland Clinic notes that among GLP-1 agonists, the FDA has approved semaglutide and high-dose liraglutide specifically for obesity treatment.
The landmark trial is STEP 1, published in the New England Journal of Medicine. It ran 68 weeks with 1,961 adults with overweight or obesity, comparing once-weekly semaglutide 2.4 mg plus lifestyle intervention against placebo plus the same lifestyle intervention.
The results:
For a 240-pound man, a 14.9% average works out to roughly 36 pounds over about sixteen months. That is a real number from a real trial, not a marketing figure, and it is an average rather than a promise.
Half the participants on semaglutide lost 15% or more of their body weight. That is a result diet and exercise alone almost never produces at scale, which is exactly why the medication changed the conversation.
Gastrointestinal effects are common and were the most frequently reported events in STEP 1, occurring in 74.2% of the semaglutide group compared with 47.9% of the placebo group. Cleveland Clinic lists nausea, vomiting, diarrhea, and reduced appetite as the usual ones, most pronounced when starting the medication or stepping up a dose.
They are also the main reason men quit in month one. Careful dose escalation and a provider who adjusts the pace rather than pushing through the schedule make most of the difference. That is a clinical judgment call, not something an algorithm handles well.
Serious adverse events were reported in 10% of the semaglutide group versus 6.4% on placebo, with gallbladder-related disorders higher in the treatment group. The National Institute of Diabetes and Digestive and Kidney Diseases also notes that GLP-1 medications are not appropriate for people with a personal or family history of certain thyroid cancers, and are not recommended during pregnancy or breastfeeding.
NIDDK sets out the standard criteria for prescription weight management medication: a BMI of 30 or greater, or a BMI of 27 or greater alongside a weight-related condition such as high blood pressure or type 2 diabetes.
NIDDK also frames the expectation honestly. On average, after one year, adults taking prescription weight management medication as part of a lifestyle program lose 3% to 12% more of their starting body weight than lifestyle changes alone. The medication is a tool inside a program, not a replacement for one.
At CarePrime Men the GLP-1 program runs at $199 per month, and that covers the medical consultation, the medication through a licensed pharmacy, dose adjustments, and nutrition guidance. Tirzepatide and higher-dose options are available by consultation. Full details are on the Treatments page, and pricing is published openly on the Pricing page with no bundling games.
The structure matters as much as the molecule. One provider, Christopher Brown, FNP-C, manages the protocol start to finish, which means the person adjusting your dose in month four is the same person who took your history in week one. How It Works walks through the full sequence, and if you are weighing whether virtual care is the real thing, our guide to how online men's health care works in Georgia covers what a visit involves and how to vet a practice.
Worth knowing if you are a man over 40: excess body fat and low testosterone tend to travel together, each making the other harder to fix. Cleveland Clinic lists increased body fat among the symptoms of low testosterone, and men carrying significant weight are more likely to test low.
That is why CarePrime Men offers a combined membership starting at $299 per month for men who need both, coordinated under a single provider rather than run as two disconnected prescriptions. If the fatigue has been as stubborn as the weight, start with our guide to low testosterone symptoms, then the safety picture and what TRT costs in Georgia, or take the free ADAM symptom check.
CarePrime Men is licensed in Georgia and works with men across Brunswick, St. Simons Island, Jekyll Island, Darien, and the wider Golden Isles, entirely by telemedicine. There is no waiting room and no drive. Common questions are answered on the FAQs page, and a free consultation starts through the contact form.
This article is general health education, not medical advice. GLP-1 medications are not appropriate for everyone, and eligibility requires a clinical evaluation. Talk with a licensed provider about your own situation.
